Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Titel:
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Auteur:
Adams, S. Loi, S. Toppmeyer, D. Cescon, D.W. De Laurentiis, M. Nanda, R. Winer, E.P. Mukai, H. Tamura, K. Armstrong, A. Liu, M.C. Iwata, H. Ryvo, L. Wimberger, P. Rugo, H.S. Tan, A.R. Jia, L. Ding, Y. Karantza, V. Schmid, P.